Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

323 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Human APOBEC3B promotes tumor heterogeneity in vivo including signature mutations and metastases.
Durfee C, Temiz NA, Levin-Klein R, Argyris PP, Alsøe L, Carracedo S, de la Vega AA, Proehl J, Holzhauer AM, Seeman ZJ, Lin YT, Vogel RI, Sotillo R, Nilsen H, Harris RS. Durfee C, et al. Among authors: nilsen h. bioRxiv [Preprint]. 2023 Feb 25:2023.02.24.529970. doi: 10.1101/2023.02.24.529970. bioRxiv. 2023. Update in: Cell Rep Med. 2023 Oct 17;4(10):101211. doi: 10.1016/j.xcrm.2023.101211. PMID: 36865194 Free PMC article. Updated. Preprint.
Human APOBEC3B promotes tumor development in vivo including signature mutations and metastases.
Durfee C, Temiz NA, Levin-Klein R, Argyris PP, Alsøe L, Carracedo S, Alonso de la Vega A, Proehl J, Holzhauer AM, Seeman ZJ, Liu X, Lin YT, Vogel RI, Sotillo R, Nilsen H, Harris RS. Durfee C, et al. Among authors: nilsen h. Cell Rep Med. 2023 Oct 17;4(10):101211. doi: 10.1016/j.xcrm.2023.101211. Epub 2023 Oct 4. Cell Rep Med. 2023. PMID: 37797615 Free PMC article.
Complete response of metastatic microsatellite-stable BRAF V600E colorectal cancer to first-line oxaliplatin-based chemotherapy and immune checkpoint blockade.
Ree AH, Høye E, Esbensen Y, Beitnes AR, Negård A, Bernklev L, Tetlie LK, Fretland ÅA, Hamre HM, Kersten C, Hofsli E, Guren MG, Sorbye H, Nilsen HL, Flatmark K, Meltzer S. Ree AH, et al. Among authors: nilsen hl. Oncoimmunology. 2024 Jun 28;13(1):2372886. doi: 10.1080/2162402X.2024.2372886. eCollection 2024. Oncoimmunology. 2024. PMID: 38952672 Free PMC article. Clinical Trial.
Decompression alone or with fusion for degenerative lumbar spondylolisthesis (Nordsten-DS): five year follow-up of a randomised, multicentre, non-inferiority trial.
Kgomotso EL, Hellum C, Fagerland MW, Solberg T, Brox JI, Storheim K, Hermansen E, Franssen E, Weber C, Brisby H, Algaard KRH, Furunes H, Banitalebi H, Ljøstad I, Indrekvam K, Austevoll IM; Nordsten collaborators. Kgomotso EL, et al. BMJ. 2024 Aug 7;386:e079771. doi: 10.1136/bmj-2024-079771. BMJ. 2024. PMID: 39111800 Free PMC article. Clinical Trial.
Nicotinamide riboside first alleviates symptoms but later downregulates dopamine metabolism in proteasome inhibition mouse model of Parkinson's disease.
Turconi G, Alam F, SenGupta T, Pirnes-Karhu S, Olfat S, Schmidt MS, Mätlik K, Montaño-Rodriguez A, Heiskanen V, Garton D, Piepponen PT, Brenner C, Holmberg CI, Nilsen H, Pirinen E, Andressoo JO. Turconi G, et al. Among authors: nilsen h. Heliyon. 2024 Jul 9;10(14):e34355. doi: 10.1016/j.heliyon.2024.e34355. eCollection 2024 Jul 30. Heliyon. 2024. PMID: 39108921 Free PMC article.
323 results